Abstract
Microglia, the resident macrophages of the central nervous system (CNS), are activated by a myriad of signaling molecules including ATP, an excitatory neurotransmitter and neuron-glial signal with both neuroprotective and neurotoxic effects. The “microglial dysfunction hypothesis” of neurodegeneration posits that overactivated microglia have a reduced neuroprotective capacity and instead promote neurotoxicity. The chemokine fractalkine (FKN), one of only two chemokines constitutively expressed in the CNS, is neuroprotective in several in vivo and in vitro models of CNS pathology. It is possible, but not yet demonstrated, that high ATP concentrations induce microglial overactivation and apoptosis while FKN reduces ATP-mediated microglial overactivation and cytotoxicity. In the current study, we examined the effects of FKN on ATP-induced microglial apoptosis and the underlying mechanisms in the BV-2 microglial cell line. Exposure to ATP induced a dose-dependent reduction in BV-2 cell viability. Prolonged exposure to a high ATP concentration (3 mM for 2 h) transformed ramified (quiescent) BV-2 cells to the amoebic state, induced apoptosis, and reduced Akt phosphorylation. Pretreatment with FKN significantly inhibited ATP-induced microglial apoptosis and transformed amoebic microglia to ramified quiescent cells. These protective effects were blocked by chemical inhibition of PI3 K, strongly implicating the PI3 K/Akt signaling pathway in FKN-mediated protection of BV-2 cells from cytotoxic ATP concentrations. Prevention of ATP-induced microglial overactivation and apoptosis may enhance the neuroprotective capacity of these cells against both acute insults and chronic CNS diseases.
Similar content being viewed by others
References
Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
Garden GA, Möller T (2006) Microglia biology in health and disease. J Neuroimmune Pharm 1:127–137
Kim WK, Hwang SY, Oh ES, Piao HZ, Kim KW et al (2004) TGF-beta 1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol 172:7015–7023
Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775–787
Tambuyzer BR, Ponsaerts P, Nouwen EJ (2009) Microglia: gatekeepers of central nervous system immunology. J Leukocyte Biol 85:352–370
Monk PN, Shaw PJ (2006) ALS: life and death in a bad neighborhood. Nat Med 12:885–887
Neumann H, Kotter MR, Franklin RJ (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132:288–295
Liu B, Wang K, Gao HM, Mandavilli B, Wang JY et al (2001) Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 77:182–189
Polazzi E, Monti B (2010) Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 92:293–315
Liang J, Takeuchi H, Jin S, Noda M, Li H et al (2010) Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway. Brain Res 1322:8–23
Nakamura Y (2002) Regulating factors for microglial activation. Biol Pharm Bull 25:945–953
Matute C, Alberdi E, Domercq M, Sánchez-Gómez M-V, Pérez-Samartín A et al (2007) Excitotoxic damage to white matter. J Anat 210:693–702
Fields RD, Burnstock G (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7:423–436
Delarasse C, Gonnord P, Galante M, Auger R, Daniel H et al (2009) Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 109:846–857
Matute C (2011) Glutamate and ATP signalling in white matter pathology. J Anat 219:53–64
Farber K, Kettenmann H (2006) Purinergic signaling and microglia. Pflugers Arch 452:615–621
Re DB, Przedborski S (2006) Fractalkine: moving from chemotaxis to neuroprotection. Nat Neurosci 9:859–861
Cipriani R, Villa P, Chece G, Lauro C, Paladini A et al (2011) CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci 31:16327–16335
Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC (2011) CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease. J Neuroinflamm 8:9
Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM et al (2011) CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci 31:16241–16250
Fuhrmann M, Bittner T, Jung CKE, Burgold S, Page RM et al (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat Neurosci 13:411–413
Mizuno T, Kawanokuchi J, Numata K, Suzumura A (2003) Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979:65–70
Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L et al (2008) Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J Immunol 180:7590–7596
Limatola C, Lauro C, Catalano M, Ciotti MT, Bertollini C et al (2005) Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol 166:19–28
Deiva K, Geeraerts T, Salim H, Leclerc P, Hery C et al (2004) Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur J Neurosci 20:3222–3232
Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ (2000) The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 165:397–403
Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27:229–237
Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R et al (2012) Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Delta9-tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol 165:2512–2528
Lee P, Hur J, Lee J, Kim J, Jeong J et al (2006) 15,16-dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide. Neurochem Int 48:60–66
Lee JA, Song HY, Ju SM, Lee SJ, Seo WY et al (2010) Suppression of inducible nitric oxide synthase and cyclooxygenase-2 by cell-permeable superoxide dismutase in lipopolysaccharide- stimulated BV-2 microglial cells. Mol Cells 29:245–250
Shen S, Yu S, Binek J, Chalimoniuk M, Zhang X et al (2005) Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int 47:298–307
Lee S, Lee J, Kim S, Park JY, Lee WH et al (2007) A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol 179:3231–3241
Shigemoto-Mogami Y, Koizumi S, Tsuda M, Ohsawa K, Kohsaka S et al (2001) Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem 78:1339–1349
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y et al (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752–758
Xiang Z, Chen M, Ping J, Dunn P, Lv J et al (2006) Microglial morphology and its transformation after challenge by extracellular ATP in vitro. J Neurosci Res 83:91–101
Choi DK, Koppula S, Suk K (2011) Inhibitors of microglial neurotoxicity: focus on natural products. Molecules 16:1021–1043
Hu X, Zhou H, Zhang D, Yang S, Qian L et al (2012) Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation. J Neuroimmune Pharm 7:187–201
Zujovic V, Benavides J, Vige X, Carter C, Taupin V (2000) Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29:305–315
Noda M, Doi Y, Liang J, Kawanokuchi J, Sonobe Y et al (2011) Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J Biol Chem 286:2308–2319
Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917–924
Vinet J, van Weering HR, Heinrich A, Kalin RE, Wegner A et al (2012) Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflamm 9:27
Lyons A, Lynch AM, Downer EJ, Hanley R, O’Sullivan JB et al (2009) Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem 110:1547–1556
Acknowledgments
This work was supported by a grant from the Natural Science Foundation of Liaoning Province, China (No. 201202050). Authors are grateful to Dr. Ying Zhao for technical expertise and Prof. Qigui Liu, a statistical expert, for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Additional information
Fei Hao and Nan-Nan Zhang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Hao, F., Zhang, NN., Zhang, DM. et al. Chemokine Fractalkine Attenuates Overactivation and Apoptosis of BV-2 Microglial Cells Induced by Extracellular ATP. Neurochem Res 38, 1002–1012 (2013). https://doi.org/10.1007/s11064-013-1010-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-013-1010-7